Dr. Mark Edmund Bernard, MD

Dr. Bernard practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Bernard's NPI, 1932468246, was assigned on May 7, 2012. Dr. Bernard graduated from University of Pittsburgh School of Medicine in 2012. Dr. Bernard holds Kentucky license 50281.

Dr. Bernard's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Bernard's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. The medical group on file is UK HealthCare. Dmand AI also links Dr. Bernard to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernard practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bernard's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Bernard is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Bernard's licenses on file in 2 states: Kentucky and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation and pancreatic cancer radiation among the conditions Dr. Bernard treats.

CMS data shows 925 Medicare services from Dr. Bernard across 15 procedure codes in 2024, for 147 Medicare patients. Medicare paid $71,049 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 147 Medicare patients who saw Dr. Bernard in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernard's median patient age at 72, with 53% women.

In 2024, Dr. Bernard wrote 64 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $571 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Dr. Bernard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bernard as offering telehealth.

Dmand AI links 68 papers to Dr. Bernard, published from 2010 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Radiotherapy Planning, Computer-Assisted, Radiosurgery and Radiotherapy Dosage. Dr. Bernard has published most often in J Appl Clin Med Phys. Dr. Bernard's most frequent co-authors are Dwight Earl Heron, MD, Steven A. Burton, MD and Beant Singh Gill, MD.

Dmand AI links Dr. Bernard to 5 clinical trials, 3 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Meningeal Carcinomatosis and Rectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 1 general payment to Dr. Bernard from 1 drug or device company in 2023. Speaker and faculty fees make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $1,680.

Dr. Bernard graduated from University of Pittsburgh School of Medicine in 2012.

Dr. Bernard is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.